Skip to content

DOCTEUR ELSA GENDEBIEN

Active Private limited companyfounded 2022active for 3 yearsRue des Trois Mêlées 35, 4130 EsneuxKBO/BCE: BE 0794.464.543

Lifetime

3 annual accounts with figures on one time axis
peak of €48,141 in 2023
€19,380▼ 57.3%
peak of €36,332 in 2023
€11,993▼ 64.1%
peak of €84,227 in 2025
€84,227▲ 16.6%
€5,054▼ 44.9%
Board1 name since 2022
1 director
Documentsfilings and deeds
23-07-20268 days before the deadline
2025micro format
Gross margin from €45,404 to €19,380Result from €33,401 to €11,993Equity from €72,233 to €84,227Debts from €9,178 to €5,054

Key points

from the 2025 annual accounts

Turnover

≈ €120,000 estimated

The micro format states no turnover.

Liquidity

17.67 was 8.87 in 2024

Short-term debts fell from €9,178 to €5,054.

Position in the sector

94.3%

Higher solvency than 90% of companies in human health. The sector median is 63.0%, over 21,385 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,327 companies had the same profile as DOCTEUR ELSA GENDEBIEN has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,327 companies, not a prediction for DOCTEUR ELSA GENDEBIEN. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 100 sharesdeed of 08-12-2022
Board & ownership

Recent changes

Registered office moved from Liège to Fontin The registered office moved from rue Edouard Wacken 13/1, 4000 Liège to Rue des Trois Mêlées 35, 4130 Fontin · General meeting of 16-09-2026 · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:0794464543
Incorporation Founding capital of €2,500, 100 shares · Founded by · appointed as director · published on 08-12-2022 · Gazette deed
First establishment Rue Edouard-Wacken 13, Liège
All 9 events

Comparable companies

same main activity, similar in size and age
Company
DOCTEUR ELSA GENDEBIEN Esneux €89,281 €19,380 94.3% -
Dr. Janne Morlion Beernem €99,714 €19,588 49.6% -
DR. CARNOY, SPOEDARTS Hoegaarden €78,160 €20,893 92.1% -
Dokter Annelies Belmans Tielt-Winge €75,787 €18,566 3.2% -
Docteur Conte Thibault Seraing €94,522 €21,521 17.5% -
Docteur Camille BOTTY Blegny €75,954 €17,140 58.0% -
DR. CAROLINE STEVENS, HUISARTS Aalter €97,378 €19,417 50.8% -

These companies have the same main activity as DOCTEUR ELSA GENDEBIEN: general medical practice (NACE 86210). They are comparable in size and age: total assets between €75,800 and €99,700, founded between 2021 and 2024.

Official details

Source: KBO
Status
Active since 06-12-2022Normal situation
Activity
General medical practiceNACE 86210
Establishment unit
2.339.616.0464000 Liège, since 06-12-2022
Financial year end
31 December
Peppol
Reachable since 06-12-2025
Company details

Annual accounts 2025

€89,281▲ 9.7%
Filing
Filed on 23-07-2026, 8 days before the end of the filing period
Financials

Insights on DOCTEUR ELSA GENDEBIEN

DOCTEUR ELSA GENDEBIEN files the micro format. That format states no turnover. The gross margin fell from €48,141 in 2023 to €19,380 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DOCTEUR ELSA GENDEBIEN

What is the company number of DOCTEUR ELSA GENDEBIEN?
The company number of DOCTEUR ELSA GENDEBIEN is 0794.464.543. The VAT number is the same number with BE in front: BE 0794.464.543.
Where is DOCTEUR ELSA GENDEBIEN based?
The registered office is at Rue des Trois Mêlées 35, 4130 Esneux.Company details
What does DOCTEUR ELSA GENDEBIEN do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of DOCTEUR ELSA GENDEBIEN?
DOCTEUR ELSA GENDEBIEN is a private limited company (BV).
When was DOCTEUR ELSA GENDEBIEN founded?
DOCTEUR ELSA GENDEBIEN was founded on 06-12-2022.
Is DOCTEUR ELSA GENDEBIEN still active?
Yes, DOCTEUR ELSA GENDEBIEN is an active enterprise in the KBO register.
What is the turnover of DOCTEUR ELSA GENDEBIEN?
The turnover in financial year 2025 is about €120,000. This figure is estimated from the gross margin of €19,380 and 52 comparable companies (NACE 86). It probably lies between €83,000 and €210,000. It is a rough estimate.Financials
Is DOCTEUR ELSA GENDEBIEN profitable?
In financial year 2025, DOCTEUR ELSA GENDEBIEN made a profit of €11,993.
Where can I find the annual accounts of DOCTEUR ELSA GENDEBIEN?
DOCTEUR ELSA GENDEBIEN filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DOCTEUR ELSA GENDEBIEN due?
DOCTEUR ELSA GENDEBIEN must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.